Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Collidion
AddedFeb 15, 2024
UpdatedJun 18, 2026
Collidion

Collidion

Series B

Collidion: A private healthcare firm innovating in medical devices and impactful drug development.

HQ
Petaluma, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Collidion Inc. was founded in August 2015 with the mission to improve global health by delivering innovative solutions to critically unmet medical needs. The company focuses on developing, acquiring, and licensing novel healthcare assets, particularly in medical devices and high-impact drugs. Collidion fosters innovation and commercializes technologies through its program-focused subsidiaries, providing them with capital, operational support, and intellectual property structuring.

Notable affiliated individuals and investors include key figures in the healthcare and biotech industries, although specific names are not mentioned. Collidion's key achievements include the successful development and commercialization of several medical devices and impactful drugs, significantly contributing to advancements in healthcare. The company's overall impact lies in its ability to address critical health challenges through innovative solutions, thereby improving patient outcomes globally.

Collidion - Similar Companies

Innovative Trauma Care logo

Innovative Trauma Care

CollaMedix logo

CollaMedix

collamedixinc.com

Blossom Innovations logo

Blossom Innovations

Hospi logo

Hospi

hospicorp.com

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Annoviant logo

Annoviant

Foundry logo

Foundry

thefoundry.com

Cognition Medical logo

Cognition Medical

eLum Technologies logo

eLum Technologies

True Concepts Medical Technologies logo

True Concepts Medical Technologies

Device Innovation Group logo

Device Innovation Group

CoLabs logo

CoLabs

colabsmedical.com

Collaborative Medical Technology logo

Collaborative Medical Technology

uLink Labs logo

uLink Labs

ulink-labs.com

Collaborative Medicinal Development logo

Collaborative Medicinal Development

colmeddev.com

Collidion - Quick Facts

Who are Collidion's competitors?

Companies similar to Collidion include Innovative Trauma Care, CollaMedix, Blossom Innovations and Hospi.

When was Collidion founded?

Collidion was founded in 2015.

Where is Collidion's headquarters located?

Collidion's headquarters is located in Petaluma, CA, US.

When was Collidion's last funding round?

Collidion's most recent funding round was for $13.2M (USD) in February 2016.

How much has Collidion raised to-date?

As of Feb 12, 2016, Collidion has raised a total of $13.2M (USD).

How many employees does Collidion have?

Collidion has 12 employees as of Feb 5, 2024.

Collidion - Classification

Ownership
  • Private
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified